Search research articles
Contact Us
Filters
Showing results (381-390 of 463) with videos related to
Page
of 47
Sort By:
Journal of Inflammation Research
|
November 24, 2025
Association Between Maternal IBD-Related Antibodies and Early Life Gut Inflammatory Status and Microbiota Composition: Insights from Cord Blood
Taegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Maternal IBD-related antibodies are associated with early life gut inflammatory status and microbiota composition: insights from cord blood
Taegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Gastroenterology
|
December 28, 2020
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner, Amanda Ricciuto, Ayanna Lewis, et al.
Gastroenterology
|
December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Julián Panés, Damián García-Olmo, Gert Van Assche, et al.
Crohn'S & Colitis 360
|
March 21, 2022
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
Quazim A Alayo, Marc Fenster, Osama Altayar, et al.
Journal of Crohn'S & Colitis
|
June 6, 2023
Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease
João Sabino, Leonid Tarassishin, Caroline Eisele, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium
Marc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
The American Journal of Gastroenterology
|
June 15, 2016
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium
Parambir S Dulai, Siddharth Singh, Xiaoqian Jiang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 7, 2015
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents
Jordan Axelrad, Oren Bernheim, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases
|
May 3, 2014
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease
Sylvie Rajca, Virginie Grondin, Edouard Louis, et al.
Page
of 47
Search research articles
Search
Showing results (381-390 of 463) with videos related to
Sort By:
Page
of 47
Journal of Inflammation Research
|
November 24, 2025
Association Between Maternal IBD-Related Antibodies and Early Life Gut Inflammatory Status and Microbiota Composition: Insights from Cord Blood
Taegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Maternal IBD-related antibodies are associated with early life gut inflammatory status and microbiota composition: insights from cord blood
Taegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Gastroenterology
|
December 28, 2020
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner, Amanda Ricciuto, Ayanna Lewis, et al.
Gastroenterology
|
December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Julián Panés, Damián García-Olmo, Gert Van Assche, et al.
Crohn'S & Colitis 360
|
March 21, 2022
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
Quazim A Alayo, Marc Fenster, Osama Altayar, et al.
Journal of Crohn'S & Colitis
|
June 6, 2023
Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease
João Sabino, Leonid Tarassishin, Caroline Eisele, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium
Marc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
The American Journal of Gastroenterology
|
June 15, 2016
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium
Parambir S Dulai, Siddharth Singh, Xiaoqian Jiang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 7, 2015
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents
Jordan Axelrad, Oren Bernheim, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases
|
May 3, 2014
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease
Sylvie Rajca, Virginie Grondin, Edouard Louis, et al.
Page
of 47